Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 2 (CITED2) (Internal Region) Peptide

CITED2 Reactivity: Human, Rat, Cow, Dog, Mouse, Pig Host: Synthetic BP, Imm
Catalog No. ABIN369568
  • Target See all CITED2 products
    CITED2 (Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 2 (CITED2))
    Protein Region
    Internal Region
    Origin
    Human, Rat, Cow, Dog, Mouse, Pig
    Source
    • 2
    Synthetic
    Application
    Blocking Peptide (BP), Immunogen (Imm)
    Sequence
    PNVIDTDFID EE
    Characteristics
    The peptide was used in the production of ABIN369568 - Goat Anti-CITED2 (Internal) Antibody. It is currently untested in blocking applications.
  • Application Notes
    When peptides are reconstituted in 200ul water, the concentration would be also 0.5mg/ml. To start, the best ratio would be 1:1 (which means molar excess of peptides relative to antibodies when identical volumes are mixed). Please mix equal volumes of peptide and antibody at the required dilution and leave at ambient temperature. Best is to have two identical blots, to be incubated with equal amount of antibodies, but one with the antibodies pre-adsorbed to the peptide for 20min. Then incubate and develop in parallel the two blots.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Reconstitute pellet in distilled water where required. For Blocking studies, reconstitute pellet in 200µl distilled water to obtain a 0.5mg/ml peptide solution.
    Buffer
    100µg of Lyophilised peptide, formulation De-ionized (DI) water.
    Storage
    -20 °C
    Storage Comment
    Shipped at ambient temperature, store at -20°C.
  • Target
    CITED2 (Cbp/p300-Interacting Transactivator, with Glu/Asp-Rich Carboxy-terminal Domain, 2 (CITED2))
    Synonyms
    mrg1 Peptide, p35srj Peptide, zgc:103418 Peptide, CITED2 Peptide, cite2 Peptide, ASD8 Peptide, MRG-1 Peptide, MRG1 Peptide, P35SRJ Peptide, VSD2 Peptide, AI835299 Peptide, ER154-like Peptide, Mrg1 Peptide, Msg2 Peptide, Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 2 Peptide, Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 Peptide, Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2 Peptide, Cbp/p300-interacting transactivator 2 Peptide, Cbp/p300-interacting transactivator, with Glu/Asp rich carboxy-terminal domain, 2 L homeolog Peptide, cited2 Peptide, CITED2 Peptide, cite2 Peptide, Cited2 Peptide, cited2.L Peptide
You are here:
Support